Search

everythinglearnresearchcommunity

for

Search:↓

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Hair loss is a common side effect of hormone treatments for cancer.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Finasteride caused serious side effects and led to six suicides.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

PLD is an effective and safer alternative for treating breast cancer.

New treatments for male hypogonadism are effective and should be personalized.

Some breast cancer chemotherapy can cause permanent hair loss.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The method effectively detects banned substances in urine for sports antidoping.

Improved Finasteride delivery for hair loss treatment.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

A male with aromatase deficiency improved bone health with estradiol treatment.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.